Search results for PX-TA1001

Adalimumab Biosimilar – Anti-TNF alpha mAb – Research Grade, ProteoGenix, PX-TA1001

Description of Adalimumab Biosimilar - Anti-TNF alpha mAb - Research Grade General information about Adalimumab Adalimumab is a recombinant, human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), with immunomodulating activity. Upon administration, adalimumab binds to TNF-alpha, thereby preventing its binding to the p55 and p75 TNF cell surface receptors and inhibiting TNF-mediated immune responses. TNF-alpha, a pro-inflammatory cytokine, is upregulated in various autoimmune diseases.